Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
Market Analysis and Insights: Global Pediatric Drugs and Vaccines Market
This report focuses on Global Pediatric Drugs and Vaccines LBI Global market.
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2026, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2021-2026.
Global Pediatric Drugs and Vaccines Scope and Market Size
Pediatric Drugs and Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pediatric Drugs and Vaccines market is segmented into
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application, the Pediatric Drugs and Vaccines market is segmented into
Newborn
Infant
Child
Regional and Country-level Analysis
The Pediatric Drugs and Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pediatric Drugs and Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pediatric Drugs and Vaccines Market Share Analysis
Pediatric Drugs and Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Drugs and Vaccines business, the date to enter into the Pediatric Drugs and Vaccines market, Pediatric Drugs and Vaccines product introduction, recent developments, etc.
The major vendors covered:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Market Analysis and Insights: Global Pediatric Drugs and Vaccines Market
This report focuses on Global Pediatric Drugs and Vaccines LBI Global market.
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2026, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2021-2026.
Global Pediatric Drugs and Vaccines Scope and Market Size
Pediatric Drugs and Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pediatric Drugs and Vaccines market is segmented into
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application, the Pediatric Drugs and Vaccines market is segmented into
Newborn
Infant
Child
Regional and Country-level Analysis
The Pediatric Drugs and Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pediatric Drugs and Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pediatric Drugs and Vaccines Market Share Analysis
Pediatric Drugs and Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Drugs and Vaccines business, the date to enter into the Pediatric Drugs and Vaccines market, Pediatric Drugs and Vaccines product introduction, recent developments, etc.
The major vendors covered:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
1 Study Coverage
1.1 Pediatric Drugs and Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Mumps
1.4.8 Others
1.5 Market by Application
1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Drugs and Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Drugs and Vaccines Revenue 2015-2026
2.1.2 Global Pediatric Drugs and Vaccines Sales 2015-2026
2.2 Global Pediatric Drugs and Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pediatric Drugs and Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pediatric Drugs and Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026)
3 Global Pediatric Drugs and Vaccines Competitor Landscape by Players
3.1 Global Top Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pediatric Drugs and Vaccines Manufacturers by Revenue
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Drugs and Vaccines Revenue in 2019
3.2.5 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pediatric Drugs and Vaccines Price by Manufacturers
3.4 Global Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Drugs and Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Drugs and Vaccines Sales by Type (2015-2020)
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Type (2015-2020)
4.1.3 Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Drugs and Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Drugs and Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Drugs and Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Drugs and Vaccines Sales by Application (2015-2020)
5.1.2 Global Pediatric Drugs and Vaccines Revenue by Application (2015-2020)
5.1.3 Pediatric Drugs and Vaccines Price by Application (2015-2020)
5.2 Pediatric Drugs and Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
6.1.1 United States Pediatric Drugs and Vaccines Sales YoY Growth 2015-2026
6.1.2 United States Pediatric Drugs and Vaccines Revenue YoY Growth 2015-2026
6.1.3 United States Pediatric Drugs and Vaccines Market Share in Global Market 2015-2026
6.2 United States Pediatric Drugs and Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Pediatric Drugs and Vaccines Players by Sales (2015-2020)
6.2.2 United States Top Pediatric Drugs and Vaccines Players by Revenue (2015-2020)
6.3 United States Pediatric Drugs and Vaccines Historic Market Review by Type (2015-2020)
6.3.1 United States Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
6.3.2 United States Pediatric Drugs and Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 United States Pediatric Drugs and Vaccines Price by Type (2015-2020)
6.4 United States Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026)
6.4.2 United States Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 United States Pediatric Drugs and Vaccines Price Forecast by Type (2021-2026)
6.5 United States Pediatric Drugs and Vaccines Historic Market Review by Application (2015-2020)
6.5.1 United States Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
6.5.2 United States Pediatric Drugs and Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 United States Pediatric Drugs and Vaccines Price by Application (2015-2020)
6.6 United States Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026)
6.6.2 United States Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 United States Pediatric Drugs and Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
7.2 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country
7.2.1 North America Pediatric Drugs and Vaccines Sales by Country (2015-2020)
7.2.2 North America Pediatric Drugs and Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country
8.2.1 Europe Pediatric Drugs and Vaccines Sales by Country
8.2.2 Europe Pediatric Drugs and Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country
10.2.1 Latin America Pediatric Drugs and Vaccines Sales by Country
10.2.2 Latin America Pediatric Drugs and Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
11.2.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck & Co., Inc. (USA)
12.1.1 Merck & Co., Inc. (USA) Corporation Information
12.1.2 Merck & Co., Inc. (USA) Description and Business Overview
12.1.3 Merck & Co., Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.1.5 Merck & Co., Inc. (USA) Recent Development
12.2 Abbott Laboratories (USA)
12.2.1 Abbott Laboratories (USA) Corporation Information
12.2.2 Abbott Laboratories (USA) Description and Business Overview
12.2.3 Abbott Laboratories (USA) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
12.2.5 Abbott Laboratories (USA) Recent Development
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Corporation Information
12.3.2 Amgen, Inc. (USA) Description and Business Overview
12.3.3 Amgen, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.3.5 Amgen, Inc. (USA) Recent Development
12.4 Eli Lilly and Company (USA)
12.4.1 Eli Lilly and Company (USA) Corporation Information
12.4.2 Eli Lilly and Company (USA) Description and Business Overview
12.4.3 Eli Lilly and Company (USA) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
12.4.5 Eli Lilly and Company (USA) Recent Development
12.5 F. Hoffmann-La Roche Ltd (Switzerland)
12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
12.6 Genentech, Inc. (USA)
12.6.1 Genentech, Inc. (USA) Corporation Information
12.6.2 Genentech, Inc. (USA) Description and Business Overview
12.6.3 Genentech, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.6.5 Genentech, Inc. (USA) Recent Development
12.7 GlaxoSmithKline plc. (UK)
12.7.1 GlaxoSmithKline plc. (UK) Corporation Information
12.7.2 GlaxoSmithKline plc. (UK) Description and Business Overview
12.7.3 GlaxoSmithKline plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.7.5 GlaxoSmithKline plc. (UK) Recent Development
12.8 Janssen Biologics B.V. (USA)
12.8.1 Janssen Biologics B.V. (USA) Corporation Information
12.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
12.8.3 Janssen Biologics B.V. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
12.8.5 Janssen Biologics B.V. (USA) Recent Development
12.9 Actelion Pharmaceuticals
12.9.1 Actelion Pharmaceuticals Corporation Information
12.9.2 Actelion Pharmaceuticals Description and Business Overview
12.9.3 Actelion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
12.9.5 Actelion Pharmaceuticals Recent Development
12.10 AstraZeneca Plc. (UK)
12.10.1 AstraZeneca Plc. (UK) Corporation Information
12.10.2 AstraZeneca Plc. (UK) Description and Business Overview
12.10.3 AstraZeneca Plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.10.5 AstraZeneca Plc. (UK) Recent Development
12.11 Merck & Co., Inc. (USA)
12.11.1 Merck & Co., Inc. (USA) Corporation Information
12.11.2 Merck & Co., Inc. (USA) Description and Business Overview
12.11.3 Merck & Co., Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.11.5 Merck & Co., Inc. (USA) Recent Development
12.12 Bristol-Myers Squibb Company (USA)
12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
12.12.2 Bristol-Myers Squibb Company (USA) Description and Business Overview
12.12.3 Bristol-Myers Squibb Company (USA) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bristol-Myers Squibb Company (USA) Products Offered
12.12.5 Bristol-Myers Squibb Company (USA) Recent Development
12.13 Allergan, Inc. (USA)
12.13.1 Allergan, Inc. (USA) Corporation Information
12.13.2 Allergan, Inc. (USA) Description and Business Overview
12.13.3 Allergan, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Allergan, Inc. (USA) Products Offered
12.13.5 Allergan, Inc. (USA) Recent Development
12.14 Novartis AG (Switzerland)
12.14.1 Novartis AG (Switzerland) Corporation Information
12.14.2 Novartis AG (Switzerland) Description and Business Overview
12.14.3 Novartis AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Novartis AG (Switzerland) Products Offered
12.14.5 Novartis AG (Switzerland) Recent Development
12.15 Novo Nordisk A/S (Denmark)
12.15.1 Novo Nordisk A/S (Denmark) Corporation Information
12.15.2 Novo Nordisk A/S (Denmark) Description and Business Overview
12.15.3 Novo Nordisk A/S (Denmark) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Novo Nordisk A/S (Denmark) Products Offered
12.15.5 Novo Nordisk A/S (Denmark) Recent Development
12.16 Pfizer, Inc. (USA)
12.16.1 Pfizer, Inc. (USA) Corporation Information
12.16.2 Pfizer, Inc. (USA) Description and Business Overview
12.16.3 Pfizer, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Pfizer, Inc. (USA) Products Offered
12.16.5 Pfizer, Inc. (USA) Recent Development
12.17 Sanofi S.A (France)
12.17.1 Sanofi S.A (France) Corporation Information
12.17.2 Sanofi S.A (France) Description and Business Overview
12.17.3 Sanofi S.A (France) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Sanofi S.A (France) Products Offered
12.17.5 Sanofi S.A (France) Recent Development
12.18 Shionogi Inc. (USA)
12.18.1 Shionogi Inc. (USA) Corporation Information
12.18.2 Shionogi Inc. (USA) Description and Business Overview
12.18.3 Shionogi Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Shionogi Inc. (USA) Products Offered
12.18.5 Shionogi Inc. (USA) Recent Development
12.19 Takeda
12.19.1 Takeda Corporation Information
12.19.2 Takeda Description and Business Overview
12.19.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Takeda Products Offered
12.19.5 Takeda Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Drugs and Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 Pediatric Drugs and Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Mumps
1.4.8 Others
1.5 Market by Application
1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Drugs and Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Drugs and Vaccines Revenue 2015-2026
2.1.2 Global Pediatric Drugs and Vaccines Sales 2015-2026
2.2 Global Pediatric Drugs and Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pediatric Drugs and Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pediatric Drugs and Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026)
3 Global Pediatric Drugs and Vaccines Competitor Landscape by Players
3.1 Global Top Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pediatric Drugs and Vaccines Manufacturers by Revenue
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Drugs and Vaccines Revenue in 2019
3.2.5 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pediatric Drugs and Vaccines Price by Manufacturers
3.4 Global Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Drugs and Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Drugs and Vaccines Sales by Type (2015-2020)
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Type (2015-2020)
4.1.3 Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Drugs and Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Drugs and Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Drugs and Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Drugs and Vaccines Sales by Application (2015-2020)
5.1.2 Global Pediatric Drugs and Vaccines Revenue by Application (2015-2020)
5.1.3 Pediatric Drugs and Vaccines Price by Application (2015-2020)
5.2 Pediatric Drugs and Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
6.1.1 United States Pediatric Drugs and Vaccines Sales YoY Growth 2015-2026
6.1.2 United States Pediatric Drugs and Vaccines Revenue YoY Growth 2015-2026
6.1.3 United States Pediatric Drugs and Vaccines Market Share in Global Market 2015-2026
6.2 United States Pediatric Drugs and Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Pediatric Drugs and Vaccines Players by Sales (2015-2020)
6.2.2 United States Top Pediatric Drugs and Vaccines Players by Revenue (2015-2020)
6.3 United States Pediatric Drugs and Vaccines Historic Market Review by Type (2015-2020)
6.3.1 United States Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
6.3.2 United States Pediatric Drugs and Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 United States Pediatric Drugs and Vaccines Price by Type (2015-2020)
6.4 United States Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026)
6.4.2 United States Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 United States Pediatric Drugs and Vaccines Price Forecast by Type (2021-2026)
6.5 United States Pediatric Drugs and Vaccines Historic Market Review by Application (2015-2020)
6.5.1 United States Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
6.5.2 United States Pediatric Drugs and Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 United States Pediatric Drugs and Vaccines Price by Application (2015-2020)
6.6 United States Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026)
6.6.2 United States Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 United States Pediatric Drugs and Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
7.2 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country
7.2.1 North America Pediatric Drugs and Vaccines Sales by Country (2015-2020)
7.2.2 North America Pediatric Drugs and Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country
8.2.1 Europe Pediatric Drugs and Vaccines Sales by Country
8.2.2 Europe Pediatric Drugs and Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country
10.2.1 Latin America Pediatric Drugs and Vaccines Sales by Country
10.2.2 Latin America Pediatric Drugs and Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
11.2.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck & Co., Inc. (USA)
12.1.1 Merck & Co., Inc. (USA) Corporation Information
12.1.2 Merck & Co., Inc. (USA) Description and Business Overview
12.1.3 Merck & Co., Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.1.5 Merck & Co., Inc. (USA) Recent Development
12.2 Abbott Laboratories (USA)
12.2.1 Abbott Laboratories (USA) Corporation Information
12.2.2 Abbott Laboratories (USA) Description and Business Overview
12.2.3 Abbott Laboratories (USA) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
12.2.5 Abbott Laboratories (USA) Recent Development
12.3 Amgen, Inc. (USA)
12.3.1 Amgen, Inc. (USA) Corporation Information
12.3.2 Amgen, Inc. (USA) Description and Business Overview
12.3.3 Amgen, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.3.5 Amgen, Inc. (USA) Recent Development
12.4 Eli Lilly and Company (USA)
12.4.1 Eli Lilly and Company (USA) Corporation Information
12.4.2 Eli Lilly and Company (USA) Description and Business Overview
12.4.3 Eli Lilly and Company (USA) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
12.4.5 Eli Lilly and Company (USA) Recent Development
12.5 F. Hoffmann-La Roche Ltd (Switzerland)
12.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
12.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
12.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
12.6 Genentech, Inc. (USA)
12.6.1 Genentech, Inc. (USA) Corporation Information
12.6.2 Genentech, Inc. (USA) Description and Business Overview
12.6.3 Genentech, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.6.5 Genentech, Inc. (USA) Recent Development
12.7 GlaxoSmithKline plc. (UK)
12.7.1 GlaxoSmithKline plc. (UK) Corporation Information
12.7.2 GlaxoSmithKline plc. (UK) Description and Business Overview
12.7.3 GlaxoSmithKline plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.7.5 GlaxoSmithKline plc. (UK) Recent Development
12.8 Janssen Biologics B.V. (USA)
12.8.1 Janssen Biologics B.V. (USA) Corporation Information
12.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
12.8.3 Janssen Biologics B.V. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
12.8.5 Janssen Biologics B.V. (USA) Recent Development
12.9 Actelion Pharmaceuticals
12.9.1 Actelion Pharmaceuticals Corporation Information
12.9.2 Actelion Pharmaceuticals Description and Business Overview
12.9.3 Actelion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
12.9.5 Actelion Pharmaceuticals Recent Development
12.10 AstraZeneca Plc. (UK)
12.10.1 AstraZeneca Plc. (UK) Corporation Information
12.10.2 AstraZeneca Plc. (UK) Description and Business Overview
12.10.3 AstraZeneca Plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
12.10.5 AstraZeneca Plc. (UK) Recent Development
12.11 Merck & Co., Inc. (USA)
12.11.1 Merck & Co., Inc. (USA) Corporation Information
12.11.2 Merck & Co., Inc. (USA) Description and Business Overview
12.11.3 Merck & Co., Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
12.11.5 Merck & Co., Inc. (USA) Recent Development
12.12 Bristol-Myers Squibb Company (USA)
12.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
12.12.2 Bristol-Myers Squibb Company (USA) Description and Business Overview
12.12.3 Bristol-Myers Squibb Company (USA) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bristol-Myers Squibb Company (USA) Products Offered
12.12.5 Bristol-Myers Squibb Company (USA) Recent Development
12.13 Allergan, Inc. (USA)
12.13.1 Allergan, Inc. (USA) Corporation Information
12.13.2 Allergan, Inc. (USA) Description and Business Overview
12.13.3 Allergan, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Allergan, Inc. (USA) Products Offered
12.13.5 Allergan, Inc. (USA) Recent Development
12.14 Novartis AG (Switzerland)
12.14.1 Novartis AG (Switzerland) Corporation Information
12.14.2 Novartis AG (Switzerland) Description and Business Overview
12.14.3 Novartis AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Novartis AG (Switzerland) Products Offered
12.14.5 Novartis AG (Switzerland) Recent Development
12.15 Novo Nordisk A/S (Denmark)
12.15.1 Novo Nordisk A/S (Denmark) Corporation Information
12.15.2 Novo Nordisk A/S (Denmark) Description and Business Overview
12.15.3 Novo Nordisk A/S (Denmark) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Novo Nordisk A/S (Denmark) Products Offered
12.15.5 Novo Nordisk A/S (Denmark) Recent Development
12.16 Pfizer, Inc. (USA)
12.16.1 Pfizer, Inc. (USA) Corporation Information
12.16.2 Pfizer, Inc. (USA) Description and Business Overview
12.16.3 Pfizer, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Pfizer, Inc. (USA) Products Offered
12.16.5 Pfizer, Inc. (USA) Recent Development
12.17 Sanofi S.A (France)
12.17.1 Sanofi S.A (France) Corporation Information
12.17.2 Sanofi S.A (France) Description and Business Overview
12.17.3 Sanofi S.A (France) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Sanofi S.A (France) Products Offered
12.17.5 Sanofi S.A (France) Recent Development
12.18 Shionogi Inc. (USA)
12.18.1 Shionogi Inc. (USA) Corporation Information
12.18.2 Shionogi Inc. (USA) Description and Business Overview
12.18.3 Shionogi Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Shionogi Inc. (USA) Products Offered
12.18.5 Shionogi Inc. (USA) Recent Development
12.19 Takeda
12.19.1 Takeda Corporation Information
12.19.2 Takeda Description and Business Overview
12.19.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Takeda Products Offered
12.19.5 Takeda Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Drugs and Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
